Full text loading...
n South African Pharmaceutical and Cosmetic Review - News
Implications for future R&D in neuroscience
Ganitumab disappoints in pancreatic cancer
Clinical trials making the move to emerging countries
Inspection finds manufacturing deficiencies
R&D spending up, number of approved molecules down
Gilead taunts advocacy groups with Stribild pricing
Article metrics loading...